# Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure

> **NCT02003391** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 157 (actual)

## Conditions studied

- Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Beta-blocker monotherapy
- **DRUG:** Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

## Key facts

- **NCT ID:** NCT02003391
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2016-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02003391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02003391, "Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02003391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*